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Breast self examination and survival from breast cancer
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Summary The survival of 616 women aged 15-59 with breast cancer, 226 of whom had been taught and
practised breast self examination (BSE) prior to diagnosis and 390 of whom had not, is reported. Six year
survival rates were 73.1% in the BSE taught group and 66.1% in other women (P = 0.07).
In a previously reported investigation of 616 women with
breast cancer included in a case-control study, we found an
association between tumour stage at presentation and breast
self examination (BSE) (Mant et al., 1987). Women who had
both practised and been taught BSE had more favourably
staged tumours than other women. A number of other
studies, summarised in the meta-analysis by Hill et al. (1988)
support this observation and it now seems reasonable to
conclude that, after adequate teaching and if carried out at
reasonably frequent intervals, BSE does lead to earlier diag-
nosis. It is still unclear, however, whether this earlier diag-
nosis leads to a clinically important benefit in terms of
reduced breast cancer mortality.
Overall breast cancer mortality in the UK Trial of the
Early detection of Breast Cancer (UKTEDBC, 1988) was not
reduced by mass education in BSE. However attendance at
the BSE education session was limited and Locker et al.
(1989) reported a marked difference in survival between
attenders and non-attenders. This difference could be due to
selection bias but Foster and Costanza (1984) have also
reported from Vermont, USA that 5 year survival in women
who perform BSE is 75% compared with 57% in non-
performers, and that this difference could not be accounted
for by the recorded characteristics of the women (other than
cancer stage). The only other data available are from Japan,
where Ota et al. (1989) reported a 5 year survival of 93% in
women who had discovered their breast cancer by BSE com-
pared with 85% in those who had made a fortuitous dis-
covery. It is therefore of considerable interest that the cohort
of women which we identified for our previous UK study has
now been followed up for 6 years and we report here on
whether the favourability in stage at diagnosis has been
carried through to an improvement in survival from diag-
nosis.
Method
Subjects were ever married women aged 15 to 59 years newly
presenting with breast cancer at six London hospitals
between September 1980 and December 1984. They were
interviewd by nurses as part of a large case-control study of
the relationship between oral contraceptives and breast
cancer. The women were asked whether they practised BSE,
whether they had ever been taught how to do BSE, how
often they examined their breasts and who discovered the
tumour. Breast cancer stage was established by an indepen-
dent case not review.
Of 747 women interviewed, 44 were excluded because the
cancer had been discovered other than by the woman herself.
Staging information was available for 616 of the remaining
703 women who were followed up annually from entry into
the study up to December 1989. Survival information was
added to the computer file and manually verified: deaths
from all causes are included. Loss to follow-up was small:
only 17 women had been lost at the end of year 5 although
follow-up of year 6 is still not complete for 44 women. A log
rank test was used to assess the statistical significance of the
difference between survival curves.
Results
There were 130 deaths in the group that had never been
taught BSE and 60 in the group that had been taught and
practised BSE. The overall difference in survival is shown in
Figure 1. The two survival curves began to diverge after year
1 with overall survival at the end of year 6 of 66.1% in the
non-taught group and 73.1% in the BSE taught group. This
is consistent with a lead time of about 18 months. The
difference between the curves just fails to reach conventional
levels of statistical significance (P = 0.07). Figure 2 shows
survival according to stage; the survival benefit of taught
BSE appears largely to be limited to patients with stage 1
disease, although the confidence intervals on the survival
rates for stages 2-4 are wide.
Discussion
In the women studied here the improvement in stage at
diagnosis is carried through to increased survival at 6 years.
There is a 7% probability that a difference as extreme as this
would be seen by chance, even if there was no real difference
in survival between the two groups. However, the more
important uncertainty stems from the inability of a follow-up
study to separate lead time from the effect ofearly treatment.
The improvement in survival seen is from time of diagnosis
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had been taught BSE.
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Figure 2 Survival of women according to whether or not they had been taught BSE stratified by disease stage at diagnosis.
and, unlike the UKTEDBC, this study does not allow a
direct measurement of the effect on mortality of early diag-
nosis resulting from teaching BSE. It is still possible that
many of the cancers diagnosed in the BSE taught group had
metastasised haematologically at diagnosis and the increase
in survival seen reflects only advancement of diagnosis (i.e.
lead time). However the fact that the survival benefit is
essentially limited to patients with early stage tumours is
consistent with an early treatment effect and while the sur-
vival benefit is sustained, the possibility that BSE is effective
cannot be dismissed. As a definitive randomised trial now
seems unlikely, perhaps we should accept that some women
may extend their lives through BSE, although women should
be made aware that if there is any benefit it is small in
comparison to mammographic screening. The cost of BSE,
particularly the anxiety experienced because of advancement
of diagnosis and of false positive results in younger women,
weighs heavily in formulating public health policy, and we
still do not believe that BSE should be promoted as a means
of screening for breast cancer.
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